Tenderwize
Back to tender search

Open House Discount Agreements for the Active Substance Posaconazole, ATC J02AC04

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Mar 31, 2027 · 226 days left·Open·Supplies
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Posaconazol, ATC J02AC04

65/100

Opportunity Score

PromisingLow complexity
SuppliesOpen
Why this score?

Opportunity

65 / 100

Complexity

30 / 100

Risk factors

The buyer can replace the open house agreement with exclusive contracts at any time, leading to automatic termination o...

No estimated or guaranteed contract value is provided; actual revenue depends on prescription volume and discount rates.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Strong opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Supply of pharmaceutical products containing the active substance Posaconazole (ATC J02AC04).
  • Conclusion of non-exclusive discount agreements with the buyer.
Show full summary

Open House non-exclusive discount agreements for the active substance Posaconazole (ATC J02AC04) offered by AOK Rheinland-Pfalz/Saarland. This is not a standard EU public procurement but a voluntary transparency publication. The contract runs from June 2025 to May 2027, with rolling enrollment on the first of each month. No estimated value is provided. Selection is based solely on the eligibility of the pharmaceutical product (authorized and marketable in Germany). No award criteria or competitive evaluation apply.

Risks

The buyer can replace the open house agreement with exclusive contracts at any time, leading to automatic termination o...

No estimated or guaranteed contract value is provided; actual revenue depends on prescription volume and discount rates.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Medicines must be authorized and marketable in Germany.
  • Proof of marketability via Lauer-Taxe listing or AMIce database extract.

Administrative

  • Submission of signed contract documents by specific deadlines for each enrollment date.

Requirements may be incomplete.

Buyer

Lots (1)

LOT-0001

Open House Discount Agreements for the Active Substance Posaconazole, ATC J02AC04

Non-exclusive discount agreements for Posaconazole products. All interested pharmaceutical companies can join under uniform terms. The contract period is a maximum of 24 months, starting 01.06.2025. The buyer reserves the right to replace these open house agreements with exclusive contracts via regular tenders.

SuppliesEU fundedElectronic submission

Location

Eisenberg, Germany

Duration

May 2025 - May 2027

Category

Pharmaceutical products

Deadline

Deadline May 31, 2027

Procurement Details

Publication date
10 Apr 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
235079-2025

Documents (1)

Similar tenders